A major goal of this U19 is to determine how PD-1 blockade affects human antibody responses against different viral antigens. Core C will fully interrogate serum antibody responses against a range of different viruses from donors undergoing PD-1 therapy in Projects 1 and 2. The Core will standardize assays, complete assays, and provide computational support for the analyses of complex serological datasets. We will offer standardized ELISA-based services that quantify antibodies specific for 5 viruses that are relevant for Projects 1 and 2. We will also assess quality of antibody responses through ELISAs that measure relative affinities and isotype diversity. It is possible that PD-1 blockade affects antiviral antibody responses in more subtle or global ways. To address this, we will complete serological screens to examine how PD-1 blockade affects antibody responses to a large fraction of known human viruses. For this, we will use a new array-based assay, termed ?Viroscan?, that measures antibody binding to >400,000 non-redundant viral peptides. We will also offer services that intensively analyze antibody responses against a single virus (influenza). All humans are exposed to influenza virus in childhood and all adult encounters with influenza involve both the recall of memory B cells and the stimulation of de novo B cell responses. Our influenza virus antigenic analyses will allow us to determine if PD-1 blockade differentially regulates de novo versus memory antibody responses. Together, these standardized services will allow for the complete antigenic characterization of serum samples for Projects 1 and 2.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
2U19AI082630-11
Application #
9674815
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2019-06-01
Budget End
2020-05-31
Support Year
11
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02114
Gordon, Claire Louse; Lee, Lian Ni; Swadling, Leo et al. (2018) Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8+ T Cells by Persistent Viruses and Vaccines. Cell Rep 23:768-782
Duan, Xiaoqiong; Li, Shilin; Holmes, Jacinta A et al. (2018) MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway. J Virol 92:
Bengsch, Bertram; Ohtani, Takuya; Khan, Omar et al. (2018) Epigenomic-Guided Mass Cytometry Profiling Reveals Disease-Specific Features of Exhausted CD8 T Cells. Immunity 48:1029-1045.e5
Liu, Xiao; Duan, Xiaoqiong; Holmes, Jacinta A et al. (2018) A novel lncRNA regulates HCV infection through IFI6. Hepatology :
Chen, Gang; Huang, Alexander C; Zhang, Wei et al. (2018) Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560:382-386
Ussher, James E; Willberg, Christian B; Klenerman, Paul (2018) MAIT cells and viruses. Immunol Cell Biol 96:630-641
Bengsch, Bertram; Ohtani, Takuya; Herati, Ramin Sedaghat et al. (2018) Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns. J Immunol Methods 453:3-10
Stelekati, Erietta; Chen, Zeyu; Manne, Sasikanth et al. (2018) Long-Term Persistence of Exhausted CD8 T Cells in Chronic Infection Is Regulated by MicroRNA-155. Cell Rep 23:2142-2156
Kurioka, Ayako; van Wilgenburg, Bonnie; Javan, Reza Rezaei et al. (2018) Diverse Streptococcus pneumoniae Strains Drive a Mucosal-Associated Invariant T-Cell Response Through Major Histocompatibility Complex class I-Related Molecule-Dependent and Cytokine-Driven Pathways. J Infect Dis 217:988-999
Qu, Chen; Zheng, Dandan; Li, Sai et al. (2018) Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis. Hepatology :

Showing the most recent 10 out of 173 publications